Skip to main content
McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
719.51
+6.65 (0.93%)
May 30, 2025, 4:00 PM - Market closed

McKesson Revenue

In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth. McKesson had revenue of $90.82B in the quarter ending March 31, 2025, with 18.95% growth.

Revenue (ttm)
$359.05B
Revenue Growth
+16.22%
P/S Ratio
0.26
Revenue / Employee
$7,040,216
Employees
51,000
Market Cap
90.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025359.05B50.10B16.22%
Mar 31, 2024308.95B32.24B11.65%
Mar 31, 2023276.71B12.75B4.83%
Mar 31, 2022263.97B25.74B10.80%
Mar 31, 2021238.23B7.18B3.11%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

MCK News

More News